期刊文献+

人C-反应蛋白重组真核表达质粒的构建及其对人脐静脉内皮细胞LOX-1和TF表达的影响 被引量:1

Construction of recombinant eukaryotic expression vector for human C-reactive protein and its effect on expressions of LOX-1 and TF in human umbilical vein endothelial cells
原文传递
导出
摘要 目的构建人C-反应蛋白(C-reactive protein,CRP)重组表达质粒pTracer CMV2-CRP,并观察其在人脐静脉内皮细胞(Human umbilical vein endothelical cells,HUVEC)中的表达及其对凝集素样氧化型低密度脂蛋白受体-1(Lectin-type oxidizedLDL receptor-1,LOX-1)、组织因子(Tissue factor,TF)表达的影响。方法以质粒pCR-BluntⅡ-TOPO-CRP为模板,PCR扩增CRP基因CDS序列,克隆至pTracer CMV2载体中,转化感受态大肠杆菌DH5α,构建重组表达质粒pTracer CMV2-CRP,转染HUVEC,设实验组(转染pTracer CMV2-CRP)、阴性对照组(转染pTracer-CMV2)及正常对照组,各组细胞经G418抗性筛选,RT-PCR及Western b1ot检测CRP基因的过表达效应及CRP的表达对HUVEC中LOX-1和TF转录及蛋白水平的影响。结果重组真核表达质粒pTracer CMV2-CRP经双酶切鉴定及测序证明构建正确。实验组细胞中,CRP基因过表达,且LOX-1和TF基因的转录及蛋白水平明显高于正常对照组和阴性对照组(P<0.05)。结论已成功构建人CRP基因重组真核表达质粒pTracerCMV2-CRP,并在HUVEC中过表达CRP,且明显上调HUVEC中LOX-1和TF的表达,为进一步阐述CRP在动脉粥样硬化形成过程中的作用提供了新的实验依据。 Objective To construct the recombination eukaryotic expression vector pTracer CMV2-CRP for C-reactive protein(CRP) and observe its effect on expressions of lectin-type oxidized low-density lipoprotein receptor-1(LOX-1) and tissue factor(TF) in human umbilical vein endothelial cells(HUVECs).Methods The CDS sequence of CRP gene was amplified by PCR using plasmid pCR-BluntⅡ-TOP O-CRP as a template and cloned into vector pTracer CMV2.The constructed recombinant plasmid pTracer CMV2-CRP was transfected to HUVECs,using the HUVECs transfected with pTracer-CMV2 as negative control and those untransfected as normal control.The stably transfected HUVECs in various groups were screened with G418,in which the overexpression of CRP gene as well as the effect of CRP expression on LOX-1 and TF mRNA and protein levels in HUVECs were determined by RT-PCR and Western blot.Results Restriction and sequencing proved that recombinant plasmid pTracer CMV2-CRP was constructed correctly.CRP gene was over-expressed in HUVECs transfected with the plasmid,while the LOX-1 and TF mRNA and protein levels were significantly higher than those in normal and negative control groups.Conclusion Eukaryotic expression vector pTracer CMV2-CRP was constructed successfully,and CRP gene was over-expressed in HUVECs,while the expressions of LOX-1 and TF were up-regulated significantly,which provided a new evidence for further study on the role of CRP in atherogenesis.
出处 《中国生物制品学杂志》 CAS CSCD 2012年第11期1476-1481,共6页 Chinese Journal of Biologicals
关键词 C反应蛋白质 低密度脂蛋白受体 组织因子 基因表达 人脐静脉内皮细胞 C-reactive protein(CRP) Low-density lipoprotein receptor-1(LOX-1) Tissue factor Gene expression Human umbilical vein endothelial cells(HUVECs)
  • 相关文献

参考文献13

  • 1Zhang NN, Andresen BT, Zhang CH, et al. Inflammation anti reactive oxygen species in cardiovascular disease [J]. World J Cardiol, 2010, 2(12): 408-410.
  • 2Liu H, Zhao D, Ma CS, et al. C-reactive protein predicts the severily of coronary artery disease beyond low-density lipoprotein cholesterol [J ]. Angiology, 2012, 63 (3) : 218-222.
  • 3汪克纯,王曦,王玉璟,张冬颖,覃数,常广磊.冠心病患者血清可溶性OX40配体和CRP水平的临床意义[J].中国生物制品学杂志,2010,23(10):1116-1119. 被引量:1
  • 4Wang Q, Zhu X, Xu Q, et al. Effect of C-reactive protein on gene expression in vascular endothelial cells [J]. Am J Physiol Heart Circ Physiol, 2005, 288 (4): H1539-H1545.
  • 5Calabro P, Golia E, Yeh ET. CRP and the risk of atherosclerotic events [ J ]. Semin Immunopathol, 2009,31( 1 ) : 79-94.
  • 6Verma S, Szmitko PE, Ridker PM. C-reactive protein comes of age [J]. Nat Clin Pract Cardiovasc Med, 2005, 2 (1):29-36.
  • 7Scirica BM, Morrow DA. Is C-reactive protein an innocent by- stander or proatherogenic culprit? The verdict is still out [J]. Circulation, 2006,113 ( 17 ) : 2128-2134, 2151.
  • 8Puccetti L, Pasqui AL, Bruni F, et ol. Lectin-like oxidized-LDL receptor-1 (LOX-1) polymorphisms influence cardiovascular events rate during statin treatment [J].Int J Cardiol, 2007, 119 (1): 41-47.
  • 9Montero I, Orbe J, Varo N, et al. C-reactive protein induces matrix metalloproteinase-1 and -10 in human endothelial ceUs: implications for clinical and subclinical atherosclerosis [J]. J Am Coll Cardiol,2006,47 (7) : 1369-1378.
  • 10Li L, Roumeliotis N, Sawamura T, et al. C-Reactive protein en- hances LOX-1 expression in human aortic endothelial cells rele- vance of LOX-1 to C-reactive protein-induced endothelial dys- function [J]. Circ Res, 2004, 95 (9): 877-883.

二级参考文献33

  • 1Galkina E, Ley K. Immune and inflammatory mechanisms of atherosclerosis( * ) [ J ]. Annu Rev Immunol, 2009, 27 (4): 165-197.
  • 2Mendel I,Shevach EM. Activated T cells express the OX40 ligand:requirements for induction and costimulatory function [J]. Immunology, 2006, 117(2): 196-204.
  • 3Wang X, Ria M, Kelmenson PM, et al. Positional identification of TNFSF4, encoding OX40 ligand, as a gene that influences atherosclerosis susceptibility [J]. Nat Genet, 2005, 37 (4): 365- 372.
  • 4Lizardi-Cervera J, Chavez-Tapia NC, Perez-Bautista O, et al. Association among C-reactive protein, fatty liver disease, and cardiovascular risk [J]. Dig Dis Sci, 2007, 52(9): 2375-2379.
  • 5Lowe GD. The association between elevated levels of inflammation biomarkers and coronary artery disease and death [J]. CMAJ, 2006, 174(4): 479-480.
  • 6Tricoci P, Allen JM, Kramer JM, et al. Scientific evidence underly- ing the ACC/AHA clinical practice guidelines [J].JAMA, 2009, 301(8): 831-841.
  • 7Sugamura K,Ishii N,Weinberg AD. Therapeutic targeting of the effector T-cell co-stimulatory molecule OX40 [J]. Nat Rev Immunol, 2004, 4 (6): 420-431.
  • 8Paigen B, Mitchell D, Reue K, et al. Ath-1, a gene determining atherosclerosis susceptibility and high density lipoeprotein levels in mice [J]. Proc Natl Acad Sci USA, 1987, 84 (11): 3763-3767.
  • 9Ria M, Eriksson P, Boquist S, et ol. Human genetic evidence that OX40 is implicated in myocardial infarction [J]. Biochem Biophys Res Commun, 2006, 339(3): 1001-1006.
  • 10Shankar A, Li J, Nieto FJ, et al. Association between C-reactive protein level and peripheral arterial disease among US adults without cardiovaseular disease, diabetes, or hypertension [J]. Am Heart J, 2007, 154 (3): 495-501.

共引文献4

同被引文献5

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部